Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
New alliance between PSA and SHPA announced
At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...
Case study: How Anh solved her son’s problem headaches
If your patient is struggling with persistent headaches and sinus pain, allergies could be the cause.
Complementary medicines during cold and flu season
As cold and flu season reaches fever pitch, the demand for complementary medicines to help prevent and manage colds and influenza is increasing. A...
Transforming medicine safety in aged care
PSA’s 2025 Early Career Pharmacist of the Year, Dr Kate Wang is shaping pharmacy education and aged care policy.
TGA changes continue to impact and sometimes baffle pharmacists
A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...













